Library of Congress

Law Library of Congress

The Library of Congress > Law Library > News & Events > Global Legal Monitor

Iran: New Law Poses Health and Financial Problems for Thalassemia Sufferers

(Sept. 27, 2017) A recent Iranian law that in effect removes all foreign medications from the list of drugs covered by insurance organizations reportedly endangers the health of a large percentage of the country’s thalassemia patients and subjects them to heavy financial burdens.  (Law Creating Hurdles for Thalassemia Patients, FINANCIAL TRIBUNE (July 26, 2017).)  The […]

Germany: Medical Marijuana Act Enters into Force

(Mar. 13, 2017) On March 10, 2017, an amendment to the Narcotic Drugs Act entered into force in Germany that allows doctors to prescribe cannabis to seriously ill patients even if other treatment options are available.  No additional special permit will be required.  The costs of the treatment will be covered by the patient’s health […]

United Kingdom: Record-Breaking Multi-Million Dollar Fine Imposed on Drug Companies for Charging Excessive Prices

(Dec. 23, 2016) The Competition and Markets Authority (CMA) of the United Kingdom, an independent non-ministerial department responsible for promoting competition, has fined pharmaceutical companies Pfizer and Flynn Pharma a record-breaking £90 million (about US$113 million) for charging excessive and unfair prices in the UK for an anti-epilepsy drug known as phenytoin sodium.  (Press Release, […]

Brazil: Marijuana-Based Medicine Authorized for Use

(Nov. 29, 2016) On November 22, 2016, the Board of Directors of the Brazilian Health Surveillance Agency (Agência Nacional de Vigilância Sanitária, ANVISA) unanimously approved the inclusion of medicines based on derivatives of cannabis sativa (cannabidiol and tetrahydrocannabinol – substances found in marijuana) in list A3 of Administrative Act No. 344/98. (Portaria SVS/MS No. 344/98 […]

Brazil: Import and Use of Marijuana-Based Medicine Products Authorized

(Mar. 28, 2016) On March 18, 2016, the Brazilian Health Surveillance Agency (Agência Nacional de Vigilância Sanitária, ANVISA) enacted Collegiate Board Resolution No. 66 (Resolução da Diretoria Colegiada – RDC No. 66 de 18 de Março, D.O.U. No. 54, de 21 de Março de 2016), which was published in the country’s Official Gazette (Diário Oficial […]

Canada: Update: Health Canada Responds to Supreme Court Ruling on Cannabis

(July 13, 2015) On July 8, 2015, Health Canada, the country’s federal department in charge of public health, responded to the Supreme Court of Canada’s June 11, 2015, ruling on medical marijuana. (Statement on Supreme Court of Canada Decision in R. v. Smith [Statement], GOVERNMENT OF CANADA (July 8, 2015); Tariq Ahmad, Canada: Supreme Court […]

Canada: Supreme Court Rules That All Forms of Medical Marijuana Are Permissible

(June 19, 2015) On June 11, 2015, in the case of R. v. Smith (2015, SCC 34, JUDGMENTS OF THE SUPREME COURT OF CANADA), the Supreme Court of Canada rendered a unanimous decision stating that all forms of medical marijuana are permissible for use. The Marihuana Medical Access Regulations, issued under the Controlled Drugs and […]

Israel: New Directives on Use of Marijuana for Medical Purposes

(Jan. 6, 2014) On December 15, 2013, the Israeli government approved new directives for the distribution of cannabis to patients. The directives were proposed by the Ministry of Health, Agriculture and Internal Security (hereinafter the Ministry of Health). Cannabis is currently defined as a dangerous substance under the Dangerous Drugs Ordinance (New Version), 5733-1971 (3 […]

Peru: Anti-Drug Effort Jurisdiction and Drug Registry

(Sept. 16, 2008) On July 8, 2008, President Alan Garcia Perez of Peru promulgated Law No. 29251, amending Law No. 28303 on the supervision of chemical ingredients and controlled products. The Law specifies those entities that have the authority to control and supervise material that can be used in the production of drugs and creates […]